1,000 reps gone? Managers too?

Quote

Anonymous

Guest
Dow Jones reported that up to 1,000 reps will lose jobs due to the Tekturna debaucle. That's a lot of reps and managers. Don't need half the managers we have. All 1's will be gone, whether it was this year or last. How many know what their rating was?
 






Anonymous said:
Dow Jones reported that up to 1,000 reps will lose jobs due to the Tekturna debaucle. That's a lot of reps and managers. Don't need half the managers we have. All 1's will be gone, whether it was this year or last. How many know what their rating was?
Click to expand...

ANd how do you know all 1's will be gone....let me guess you have inside info

It will end up being more like 1200 is my guess and more to come in the latter part of the year
 






Why would novartis have a layoff later in the year. After march all reinfusions for new reclast prescriptions will be generic in 2013. Merk and sanofi proved that you dont need to market an arb the last 6 mos. of life with a sales force. You just need to contract it. The exforge patent will have to have differentiators other than "intellectual property" due to the legal precedence set by the lotrel patent suit. Exelon will have to rely on contracting, not reps, to stave off generic penetration before it loses its patent later in the year. In other words NONE of these drugs will benefit much by "rep" promotion past march. They will generate similar ROI without rep promotion. Unless novartis redistributes a bunch of its current specialty drugs or buys market ready drugs from another company (unlikely at best) or has an unexpected gift regarding copd or gout drug data from the fda, you can kiss the general meds business unit goodbye. Keep in mind the current specialty force in neuro could manage the exsiting life of exelon with 1 rep in much larger geography.
 






Anonymous said:
Why would novartis have a layoff later in the year. After march all reinfusions for new reclast prescriptions will be generic in 2013. Merk and sanofi proved that you dont need to market an arb the last 6 mos. of life with a sales force. You just need to contract it. The exforge patent will have to have differentiators other than "intellectual property" due to the legal precedence set by the lotrel patent suit. Exelon will have to rely on contracting, not reps, to stave off generic penetration before it loses its patent later in the year. In other words NONE of these drugs will benefit much by "rep" promotion past march. They will generate similar ROI without rep promotion. Unless novartis redistributes a bunch of its current specialty drugs or buys market ready drugs from another company (unlikely at best) or has an unexpected gift regarding copd or gout drug data from the fda, you can kiss the general meds business unit goodbye. Keep in mind the current specialty force in neuro could manage the exsiting life of exelon with 1 rep in much larger geography.
Click to expand...

So what you are saying is every rep will be gone in January....Go have another cup of eggnog!
 












Anonymous said:
Why would novartis have a layoff later in the year. After march all reinfusions for new reclast prescriptions will be generic in 2013. Merk and sanofi proved that you dont need to market an arb the last 6 mos. of life with a sales force. You just need to contract it. The exforge patent will have to have differentiators other than "intellectual property" due to the legal precedence set by the lotrel patent suit. Exelon will have to rely on contracting, not reps, to stave off generic penetration before it loses its patent later in the year. In other words NONE of these drugs will benefit much by "rep" promotion past march. They will generate similar ROI without rep promotion. Unless novartis redistributes a bunch of its current specialty drugs or buys market ready drugs from another company (unlikely at best) or has an unexpected gift regarding copd or gout drug data from the fda, you can kiss the general meds business unit goodbye. Keep in mind the current specialty force in neuro could manage the exsiting life of exelon with 1 rep in much larger geography.
Click to expand...

Thanks Debbie downer!!
 
























High ranking reps will be let go along with the 1's (even more so) especially if your late 40's/50+ with a higher salary from all those years you were ranked, high received 3's, and got those bumps in salary. The less you make the safer you are. This is all about money now not preserving the best people. They don't need the best people now in this sales environment. Last year not all who were hit by the layoff were ranked low. High performance and top notch clinical knowledge & ability is a liability now in Pharma since they only want you to recite the PI.

"The more you know the most likely you'll go"

All the reps/managers that are 3's, high ranking, well respected by their peers will be history yet it will ,in a way, be a blessing. The best should not be in Pharma now. Consider it a compliment that they choose to lay you off. Whatever is left will not be the lowest or the highest it will be the low middle.

Pink slips have already gone out before Christmas.


Reclast reps have the edge. CV reps, it's over!!!!!!!!
 






Anonymous said:
High ranking reps will be let go along with the 1's (even more so) especially if your late 40's/50+ with a higher salary from all those years you were ranked, high received 3's, and got those bumps in salary. The less you make the safer you are. This is all about money now not preserving the best people. They don't need the best people now in this sales environment. Last year not all who were hit by the layoff were ranked low. High performance and top notch clinical knowledge & ability is a liability now in Pharma since they only want you to recite the PI.

"The more you know the most likely you'll go"

All the reps/managers that are 3's, high ranking, well respected by their peers will be history yet it will ,in a way, be a blessing. The best should not be in Pharma now. Consider it a compliment that they choose to lay you off. Whatever is left will not be the lowest or the highest it will be the low middle.

Pink slips have already gone out before Christmas.

You couldn't wait to get on here and post something you really don't know about. Yes there will be big layoffs, but how do you know who stays and who goes....All speculation

WHo already got the pink slips...If you know so much give info!!!


Reclast reps have the edge. CV reps, it's over!!!!!!!!
Click to expand...


And how do you know all this??? Who got the pink slips??? I suspect this is all speculation right now not that we won't have big layoffs but who will go/
If you think they will keep a Reclast rep over CV you are wrong. I saw it happen last year. They don't care at this point if someone has the experience or not. Remember you said it , its just a PI
 






You guys are fu****! NVS is about to give it to you good. Get ready to take one you know where. NVS could give all of you packages, hire contract field forces to do your jobs, and pay them much lower than your salaries. That would boost the share price and at the end of the day shareholders are ALL that matters. You have old drugs that have been detailed a trillion times and doctors don't care to hear what you say. Your jobs are a combination of a caterer and UPS package dropper. Anyone that has a good driving record can do your job. The gravy train is coming to an end so get ready for chaos. HAPPY FN NEW YEAR! HA!
 












Nothing wrong with idle speculation here. It is much like a group of reps sitting around a table at a hotel bar during a sales meeting speculating about a lot of things ranging from who might be in danger of losing their job to what team is going to win that night's football game.

The big unknown here is who comes to the table with good (inside) information and who is just speculating. Certainly the speculation is sometimes way off the mark but sometimes it is amazingly accurate. There are a lot of clues on the trail and most are interpretating those clues with some accuracy. In truth what happened the week before Christmas does not have the dust completely settled yet. Work force reductions were in the works prior to the Tekturna news and now the Tekturna news will deepen those cuts, it does not take a rocket scientist to see that. Folks are taking into what happened last year and that is a good foundation for the current speculation. Also hard information from a few, but they cannot give their identity away and the waters are often muddied by those who are throwing a lot of dirt in the air.

In view of industry changes, the pipeline, the patent expirations and the sudden product withdrawals I don't see how anyone could see anything less than MAJOR work force reductions, likely, and this is my speculation, at least 50% of current numbers. One could argue "why that high", but you can also say that a new product could bring in a new "starting level" sales force with just a 3 month lead. That is what happened back in 1995 when Sandoz contracted with Innovex to hire and train a new 450 rep sales force to launch Lamisil - 2 months to interview and hire and really less than 1 month to train (during December) before hitting the field to promote Lescol first, and then Lamisil when it launched.

I really don't think however (once again, my speculation, not based on inside information) that reps now covering cardiovascular will be cross trained to cover Reclast in any great numbers. Maybe a few, but really very little. Reclast is perhaps more highly dependent upon relationships that take a while to build. The company knows that and how much can be regained in that market place with a new rep with the little time left for Reclast.

So nothing wrong with speculation, it may bring new ideas to the table and it is better to vent to others in the same situation that to keep everything bottled up inside.
 






Anonymous said:
Honestly is it any different at any other company? The PHARMA gravy train is ending
Click to expand...

It's interesting in the thread it's amazing to see the rats scurry they pulled all the threads about how some backstabbing pod mates have hurt good employees.The thread referenced the gossiper who runs to their managers talking trash and lies. Then they try the classic gossip tactic spreading more lies insinuating "they don't work".

YOU KNOW WHO YOU ARE: no brains all gossip and bluster, thumping your chest claiming your the most important rep in the territory and deserve more than everyone else.

As was said before your time has come. Your vindictiveness gets you no where.
You are someone to have pity for since you are hateful,insecure,ugly on the inside and out, and restless because of it. Those you temporarily attempt to hurt will always and are victorious in the end. The best thing that can happen to you is that you change. If you stay the way you are you will never be successful or satisfied.
 






Anonymous said:
Nothing wrong with idle speculation here. It is much like a group of reps sitting around a table at a hotel bar during a sales meeting speculating about a lot of things ranging from who might be in danger of losing their job to what team is going to win that night's football game.

The big unknown here is who comes to the table with good (inside) information and who is just speculating. Certainly the speculation is sometimes way off the mark but sometimes it is amazingly accurate. There are a lot of clues on the trail and most are interpretating those clues with some accuracy. In truth what happened the week before Christmas does not have the dust completely settled yet. Work force reductions were in the works prior to the Tekturna news and now the Tekturna news will deepen those cuts, it does not take a rocket scientist to see that. Folks are taking into what happened last year and that is a good foundation for the current speculation. Also hard information from a few, but they cannot give their identity away and the waters are often muddied by those who are throwing a lot of dirt in the air.

Okay speculation #1: They are going to do things fast right after New years it's too expensive otherwise. The hotel reservations for the meetings are being re-calibrated for a smaller number of employees. Hotel business is down and they're more than happy to accommodate the reservation change. They will act fast so employees do not have time to think about their options ie. taking sick days, etc. etc.

The warn act can start in Jan saving them the money they need to pay the Alcon bill. News in Jan will be focusing on the payroll cut, unemployment compensation extension. If I were Novartis I would do it in Jan yet they're not that smart so maybe they'll wait. Sometimes they're wasteful business practices can work in everyones favor.


In view of industry changes, the pipeline, the patent expirations and the sudden product withdrawals I don't see how anyone could see anything less than MAJOR work force reductions, likely, and this is my speculation, at least 50% of current numbers. One could argue "why that high", but you can also say that a new product could bring in a new "starting level" sales force with just a 3 month lead. That is what happened back in 1995 when Sandoz contracted with Innovex to hire and train a new 450 rep sales force to launch Lamisil - 2 months to interview and hire and really less than 1 month to train (during December) before hitting the field to promote Lescol first, and then Lamisil when it launched.

I really don't think however (once again, my speculation, not based on inside information) that reps now covering cardiovascular will be cross trained to cover Reclast in any great numbers. Maybe a few, but really very little. Reclast is perhaps more highly dependent upon relationships that take a while to build. The company knows that and how much can be regained in that market place with a new rep with the little time left for Reclast.

So nothing wrong with speculation, it may bring new ideas to the table and it is better to vent to others in the same situation that to keep everything bottled up inside.
Click to expand...

okay
 






Post is correct high work force reductions in Jan. It's too expensive to allow employees any time to think about their options and hire attorneys to help them navigate their options. Future new products will be sold thru social media and a skeleton contract sales force. Legacy reps are gone.
 






Anonymous said:
Post is correct high work force reductions in Jan. It's too expensive to allow employees any time to think about their options and hire attorneys to help them navigate their options. Future new products will be sold thru social media and a skeleton contract sales force. Legacy reps are gone.
Click to expand...

K Joe thanks for the heads up!!
 






Anonymous said:
Post is correct high work force reductions in Jan. It's too expensive to allow employees any time to think about their options and hire attorneys to help them navigate their options. Future new products will be sold thru social media and a skeleton contract sales force. Legacy reps are gone.
Click to expand...

There are no legal options , why do you tools insist everytime you are on the chopping block that you have some legal recourse ?
Employee at will , period . Bend over & take dry & hard just like your predecessors .
Fucking babies
 






Anonymous said:
There are no legal options , why do you tools insist everytime you are on the chopping block that you have some legal recourse ?
Employee at will , period . Bend over & take dry & hard just like your predecessors .
Fucking babies
Click to expand...

Touchy, touchy relax my friend. Their are options! and you might not want to sign a severance
that possibly bans you from competitive employment elsewhere. Yes, at will is a big obstacle but employees do have options which won't be listed here you'll need to look into it. Check your benefits package. The longer the company waits to cut the more expensive it gets and the more the # of HR issues begin to develop.
 






Top Bottom
Back
Quote